Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
7.00
+0.01 (0.07%)
Mar 31, 2025, 1:31 PM EDT - Market open
Accolade Employees
Accolade had 2,400 employees as of February 29, 2024. The number of employees increased by 30 or 1.27% compared to the previous year.
Employees
2,400
Change (1Y)
30
Growth (1Y)
1.27%
Revenue / Employee
$186,133
Profits / Employee
-$75,124
Market Cap
573.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACCD News
- 3 days ago - Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewsWire
- 25 days ago - Accolade Welcomes Oshi Health to Trusted Partner Ecosystem - PRNewsWire
- 4 weeks ago - Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction - GlobeNewsWire
- 7 weeks ago - Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - PRNewsWire
- 2 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Accolade - PRNewsWire
- 2 months ago - ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD - Business Wire
- 2 months ago - Why Is Accolade Stock Trading Over 100% On Tuesday? - Benzinga
- 2 months ago - Healthcare M&A: Transcarent paying $621M to acquire Seattle-based health benefits firm Accolade - GeekWire